<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Gram-positive organisms, mainly coagulase-negative staphylococci (CNS) and 
 <italic>Staphylococcus aureus</italic>, are the leading cause of CRBSI in patients with cancer [
 <xref ref-type="bibr" rid="CR1">1</xref>]. However, an increasing number of episodes of CRBSI due to Gram-negative bacilli and fungi have been recently documented in some institutions [
 <xref ref-type="bibr" rid="CR5">5</xref>–
 <xref ref-type="bibr" rid="CR7">7</xref>]. In addition, an alarming emergence of antimicrobial resistance is being observed among Gram-negative bacteria infecting high-risk patients with malignancies [
 <xref ref-type="bibr" rid="CR8">8</xref>, 
 <xref ref-type="bibr" rid="CR9">9</xref>]. This is of special concern due to the associated increased mortality of bloodstream infections (BSI) due to resistant organisms in neutropenic cancer patients [
 <xref ref-type="bibr" rid="CR10">10</xref>–
 <xref ref-type="bibr" rid="CR12">12</xref>].
</p>
